Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Blackrock Durationome Trust's revenue for the
six
months ended in Dec. 2025 was $23.56 Mil.
Its revenue for the trailing twelve months (TTM) ended in Dec. 2025 was $47.51 Mil.
Blackrock Durationome Trust's Revenue per Share for the
six
months ended in Dec. 2025 was $0.60.
Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $1.23.
Warning Sign:
Blackrock Ltd Duration Income Trust revenue per share is in decline over the past 12 months.
During the past 9 years, Blackrock Durationome Trust's highest 3-Year average Revenue per Share Growth Rate was 21.80% per year. The lowest was -9.80% per year. And the median was 10.75% per year.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Blackrock Durationome Trust Revenue Related Terms
Blackrock Durationome Trust Revenue Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Asset Management subindustry, Blackrock Durationome Trust's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Blackrock Durationome Trust Revenue vs Asset Management Industry
For the Asset Management industry and Financial Services sector, Blackrock Durationome Trust's Revenue distribution charts can be found below:
* The bar in red indicates where Blackrock Durationome Trust's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $47.51 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Blackrock Durationome Trust (BLW) has a Revenue of $47.51 Mil as of Dec. 2025. Revenue is the total amount a company generates as sales through its operations. View historical data on Blackrock Durationome Trust and its competitors.
Is Blackrock Durationome Trust's Revenue too high?
Blackrock Durationome Trust's current Revenue is $47.51 Mil. Overall, Blackrock Durationome Trust has a GF Score™ of 50/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Blackrock Durationome Trust's Revenue compare to EIM and ETO?
Blackrock Durationome Trust's Revenue of $47.51 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for an Asset Management company?
A good Revenue depends on the Asset Management industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Blackrock Durationome Trust and its competitors. Blackrock Durationome Trust's current Revenue is $47.51 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Blackrock Durationome Trust stock overvalued right now?
Based on GuruFocus' analysis, Blackrock Durationome Trust (BLW) is currently considered Fairly Valued. The stock's GF Value™ is $12.15, compared to a current price of $12.81 — trading 5.4% above its estimated fair value. The current Revenue is $47.51 Mil. Blackrock Durationome Trust's overall GF Score™ is 50/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Blackrock Durationome Trust (BLW), the current Revenue is $47.51 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Blackrock Durationome Trust (BLW) Overvalued in 2026?
Based on GuruFocus' analysis, Blackrock Durationome Trust stock appears to be overvalued.
The current stock price of $12.81 is trading 5.4% above its estimated GF Value™ of $12.15.
GuruFocus considers Blackrock Durationome Trust to be Fairly Valued.
Key valuation signals for BLW:
Revenue: $47.51 Mil
GF Value™: $12.15 vs. price of $12.81 (5.4% above fair value)
No single metric tells the full story. See the BLW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Blackrock Ltd Duration Income Trust is a closed-end management investment company. Its investment objective is to provide current income and capital appreciation.
50GF Score
Get the complete analysis for BLW
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BLW has been successfully added to your 
